<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01862237</url>
  </required_header>
  <id_info>
    <org_study_id>2011.699</org_study_id>
    <nct_id>NCT01862237</nct_id>
  </id_info>
  <brief_title>Type II Diabetes Influence on Left Ventricular Remodeling and Outcomes in Patients Undergoing Aortic Valve Replacement Surgery.</brief_title>
  <acronym>DIAPASON</acronym>
  <official_title>Does Type II Diabetes Influence Prognosis and Left Ventricular Remodeling in Patients With Aortic Valve Stenosis Referred for Aortic Valve Replacement ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project focuses on the physiopathology of left ventricular remodeling associated with
      type II diabetes in patients with aortic valve stenosis referred for surgical aortic valve
      replacement.

      The main objective is to compare the reverse left ventricular remodeling between patients
      with type II diabetes and case-control patients without diabetes at one(1) year after
      surgical aortic valve replacement.

      The secondary objectives are :

        1. assess the influence of type II diabetes on left ventricular remodeling in patients
           presenting with aortic valve stenosis,

        2. assess the predictive value of myocardial fibrosis and other LV characteristics present
           prior to aortic valve surgery on the LV reverse remodeling and their influence on
           cardiovascular events at one (1) year after surgery,

        3. assess the influence of type II diabetes on cardiovascular morbidity and mortality post
           aortic valve surgery.

      The investigators main hypothesis is that patients with type II diabetes and aortic valve
      stenosis requiring aortic valve replacement have poorer LV function and less favorable post
      surgery clinical outcomes than patients without type II diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular Mass measured by echocardiography</measure>
    <time_frame>Primary outcome is assessed at one year 1 year after aortic valve replacement.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiovascular events (cardiac mortality, heart failure, atrial or ventricular rhythm abnormalities) and clinical improvement (NYHA class, 6-minute walk test).</measure>
    <time_frame>1 year after aortic valve replacement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of BNP (Brain Natriuretic Peptide).</measure>
    <time_frame>1 year after aortic valve replacement.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters.</measure>
    <time_frame>1 year after aortic valve replacement.</time_frame>
    <description>Left Ventricular Ejection Fraction, Systolic Longitudinal Strain, Systolic Circumferential Strain, Systolic Radial Strain, Diameters, wall thickness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Magnetic Resonance Imaging (MRI) parameters.</measure>
    <time_frame>1 year after aortic valve replacement.</time_frame>
    <description>LV mass, volumes, ejection fraction, replacement fibrosis mass on delayed enhanced studies, and interstitial fibrosis quantification (T1 mapping studies).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Type II Diabetes</condition>
  <arm_group>
    <arm_group_label>Patients with type II diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Type II diabetes patients with aortic valve stenosis referred for aortic valve replacement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without type II diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No type II diabetes patients with aortic valve stenosis referred for aortic valve replacement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intervention</intervention_name>
    <description>blood collection
Completion of a pre-operative cardiac MRI.
Completion of a coronary angiography examination
Completion during the surgery d'une myocardial biopsy,
Aortic echocardiographic follow-up (including post-operative ultrasound and ultrasound at 1 year
Completion of a cardiac MRI 1 year after surgery.</description>
    <arm_group_label>Patients with type II diabetes</arm_group_label>
    <arm_group_label>Patients without type II diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Arm 1: Treated Type II diabetes, Arm 2: absence of type II diabetes

          -  Aortic valve stenosis

          -  LVEF &gt; 50% with no kinetic abnormalities

          -  Non significant obstructive coronary artery disease

          -  Absence of gadolinium enhanced MRI contraindications

          -  Informed consent signed

          -  Patient affiliated to the French Social Security.

        Exclusion Criteria:

          -  Chronic arrhythmia or absence of sinus rhythm

          -  Past history of cardiomyopathy or coronary insufficiency

          -  Significant coronaropathy seen during the coronary angiography with &gt;50% degree
             stenosis prior to aortic valve replacement

          -  Hemodynamically significant valvular dysfunction other than aortic stenosis (grade 2
             mitral or aortic insufficiency, mitral valve stenosis &lt; 1.5 cm2)

          -  Systemic chronic inflammatory disease leading to cardiac injury (scleroderma)

          -  Renal insufficiency (clearance &lt; 30 ml/min)

          -  Insufficient transthoracic echocardiography echogenicity

          -  Type I diabetes mellitus

          -  Uncontrolled hypertension (&gt; 180/100 mm Hg)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hélène THIBAULT</last_name>
    <phone>4 72 35 73 32</phone>
    <phone_ext>+33</phone_ext>
    <email>helene.thibault@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Hôpital Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène THIBAULT</last_name>
      <phone>4 72 35 73 32</phone>
      <phone_ext>+33</phone_ext>
      <email>helene.thibault@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Hélène THIBAULT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2013</study_first_submitted>
  <study_first_submitted_qc>May 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2013</study_first_posted>
  <last_update_submitted>August 28, 2014</last_update_submitted>
  <last_update_submitted_qc>August 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type II diabetes</keyword>
  <keyword>aortic valve stenosis</keyword>
  <keyword>left ventricular remodeling</keyword>
  <keyword>aortic valve replacement surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Ventricular Remodeling</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

